Search results
Results from the WOW.Com Content Network
The hypoglossal nerve stimulator is a novel strategy for the treatment of obstructive sleep apnea. [ 1 ] [ 2 ] It has been gaining popularity over the last few decades and was approved in Europe in 2013 and the Food and Drug Administration (FDA) in April 2014. [ 3 ]
A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective. Inspire is a hypoglossal nerve stimulator (HNS) to treat obstructive sleep apnea.
For patients who cannot use a continuous positive airway pressure device, the U.S. Food and Drug Administration in 2014 granted pre-market approval for an upper airway stimulation system that senses respiration and delivers mild electrical stimulation to the hypoglossal nerve in order to increase muscle tone at the back of the tongue so it will ...
Criteria defining an apnea or a hypopnea vary. The American Academy of Sleep Medicine (AASM) defines an apnea as a reduction in airflow of ≥ 90% lasting at least 10 seconds. A hypopnea is defined as a reduction in airflow of ≥ 30% lasting at least 10 seconds and associated with a ≥ 4% decrease in pulse oxygenation, or as a ≥ 30% ...
Inspire is an implanted hypoglossal nerve stimulation device that treats obstructive sleep apnea by monitoring your breathing and delivering impulses to the nerve responsible for tongue movement ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...
Hypoglossal nerve stimulation, an option for some patients who have obstructive sleep apnea [28] Percutaneous tibial nerve stimulation (PTNS) for the treatment of incontinence. Peripheral nerve stimulation (PNS, which refers to simulation of nerves beyond the spine or brain, and may be considered to include occipital or sacral nerve stimulation)
For premium support please call: 800-290-4726 more ways to reach us